Phenotypic Heterogeneity of Sarcomeric Gene Mutations. A Matter of Gain and Loss?

Journal of the American College of Cardiology

Volumn 54, Issue 4, 2009, Pages 343-345

  Mestroni, Luisa ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

ANKRD1; CARP; dilated cardiomyopathy; hypertrophic cardiomyopathy; mutation; titin connectin

Indexed keywords

ANKYRIN; CARDIAC ANKYRIN REPEAT PROTEIN; CONNECTIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; NUCLEAR PROTEIN; OBSCURIN; TROPONIN C; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ANKYRIN REPEAT DOMAIN 1 GENE; CONGESTIVE CARDIOMYOPATHY; EDITORIAL; GENE; GENE OVEREXPRESSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MISSENSE MUTATION; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SARCOMERE; SIGNAL TRANSDUCTION;

CARDIOMYOPATHIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUSCLE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; REPRESSOR PROTEINS; SARCOMERES;

EID: 67650239904     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.029     Document Type: Editorial

References (16)

1. Moulik M., Vatta M., Witt S.H., et al. ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. J Am Coll Cardiol 54 (2009) 325-333
2. Arimura T., Bos J.M., Sato A., et al. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J Am Coll Cardiol 54 (2009) 334-342
3. Cinquetti R., Badi I., Campione M., et al. Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return. Hum Mutat 29 (2008) 468-474
4. Miller M.K., Bang M.L., Witt C.C., et al. The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J Mol Biol 333 (2003) 951-964
5. Zolk O., Frohme M., Maurer A., et al. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 293 (2002) 1377-1382
6. Itoh-Satoh M., Hayashi T., Nishi H., et al. Titin mutations as the molecular basis of dilated cardiomyopathy. Biochem Biophys Res Commun 291 (2002) 385-391
7. Gerull B., Gramlich M., Atherton J., et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nature Genet 30 (2002) 201-204
8. Matsumoto Y., Hayashi T., Inagaki N., et al. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J Muscle Res Cell Motil 26 (2005) 367-374
9. McKusick V.A. Online Mendelian inheritance in man, OMIM. McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD) (2000). http://www.ncbi.nlm.nih.gov/omim/ Available at: http://www.ncbi.nlm.nih.gov/omim/. Accessed June 8, 2009
10. Haines J., and Pericak-Vance M. Genetic Analysis of Complex Diseases. 2nd edition (2006), Wiley & Sons, Hoboken, NJ
11. Hershberger R.E., Lindenfeld J., Mestroni L., Seidman C.E., Taylor M.R., and Towbin J.A. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America Practice Guideline. J Card Fail 15 (2009) 83-97
12. Mizra M., Marston S., Willot R., et al. Dilated cardiomyopathy mutations in 3 thin filament regulatory proteins result in a common functional phenotype. J Biol Chem 280 (2005) 28498-28506
13. Kaski J.P., Syrris P., Burch M., et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Heart 94 (2008) 1478-1484
14. Debold E.P., Schmitt J.P., Patlak J.B., et al. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay. Am J Physiol Heart Circ Physiol 293 (2007) H284-H291
15. Rajan S., Ahmed R.P., Jagatheesan G., et al. Dilated cardiomyopathy mutant tropomyosin mice developcardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Res 101 (2007) 205-214
16. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 77 (2008) 659-666